Trial Profile
The Effect of Mirabegron on Brown Adipose Tissue in Healthy Young White Caucasian and South Asian Men
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2019
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Dyslipidaemias; Obesity
- Focus Therapeutic Use
- Acronyms MiraBAT
- 02 Dec 2017 Status changed from recruiting to completed.
- 28 Apr 2016 New trial record